The invention relates to a method comprising the step of ocular administration of therapeutically effective amounts of a nicotinic antagonist to control postnatal ocular growth or inhibit the development of myopia.
申请公布号
WO0152832(A1)
申请公布日期
2001.07.26
申请号
WO2001US01692
申请日期
2001.01.18
申请人
VALLEY FORGE PHARMACEUTICALS, INC.;STONE, RICHARD, A.;LINDSTROM, JON, M.
